Signaling pathways associated with PKG have also been linked to myocardial hypertrophy, fibrosis and angiogenesis and are potential therapeutic targets for HFpEF that are currently the focus of numerous studies. The gene discussed is PRKG1; the disease is cardiac hypertrophy.